For the quarter ending 2025-09-30, ALLR made $2,705K in revenue. -$2,806K in net income. Net profit margin of -103.73%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 1,203 | 2,321 | ||
| Impairment of intangible assets | 0 | - | ||
| General and administrative | 1,315 | 1,812 | ||
| Total operating expenses | 2,518 | 4,133 | ||
| Loss from operations | -2,518 | -4,133 | ||
| Interest income | 187 | 237 | ||
| Interest expense | 57 | 12 | ||
| Foreign exchange gains (losses) | -418 | 1,588 | ||
| Change in fair value of derivative and warrant liabilities | 0 | 0 | ||
| Total other income, net | -288 | 1,813 | ||
| Loss before income tax benefit | -2,806 | -2,320 | ||
| Income tax benefit | 0 | 0 | ||
| Net loss | -2,806 | -2,320 | ||
| Gain on extinguishment of series a convertible preferred stock-Series AConvertible Preferred Stock | 0 | 0 | ||
| Deemed dividend on preferred stock-Series APreferred Stock | 0 | - | ||
| Deemed dividend on preferred stock-Series AConvertible Preferred Stock | 0 | 0 | ||
| Net loss attributable to common stockholders | -2,806 | -2,320 | ||
| Net loss per common share, basic and diluted (in dollars per share) | -0.19 | -0.15 | ||
| Weighted average common shares outstanding, basic and diluted (in shares) | 14,739,800 | 15,543,321 | ||
Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. (ALLR)